Results 101 to 110 of about 14,810 (242)

Database Analysis of Eplerenone Use in Japanese Hypertensive Patients in Clinical Practice

open access: yesInternational Journal of Hypertension, 2019
Eplerenone, a mineralocorticoid receptor antagonist (MRA), is available in Japan, but details of its use in clinical settings have not been thoroughly investigated.
Shoko Takahashi   +4 more
doaj   +1 more source

Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial

open access: yesOrphanet Journal of Rare Diseases, 2017
Background Cardiomyopathy is a leading cause of morbidity and mortality in boys with Duchenne muscular dystrophy (DMD). We recently showed in a 12-month double-blind randomized controlled trial that adding eplerenone to background medical therapy was ...
Subha V. Raman   +8 more
doaj   +1 more source

Type of atrial fibrillation and clinical outcomes in patients with heart failure and reduced ejection fraction [PDF]

open access: yes, 2017
Background: Atrial fibrillation (AF) is common in heart failure (HF), but the outcome by type of AF is largely unknown. Objectives: This study investigated outcomes related to type of AF (paroxysmal, persistent or permanent, or new onset) in 2 ...
Abraham, William T.   +11 more
core   +3 more sources

A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy

open access: yesScientific Reports, 2017
Aldosterone antagonists slow the progression of chronic kidney disease (CKD), but their use is limited by hyperkalemia, especially when associated with RAS inhibitors.
Clarice K. Fujihara   +11 more
doaj   +1 more source

New Clinical Aspects of Eplerenone Use in Clinical Practice

open access: yesРациональная фармакотерапия в кардиологии, 2018
The problem of the discrepancy between convincing evidences of the effectiveness of the use of mineralocorticoid receptor antagonists in patients with heart failure with reduced left ventricular ejection fraction and insufficiently frequent their use in ...
S. R. Gilyarevskiy   +3 more
doaj   +1 more source

Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? [PDF]

open access: yes, 2017
Structured interventions on lifestyle have been suggested as a cost-effective strategy for prevention of cardiovascular disease. Epidemiologic studies demonstrate that dietary salt restriction effectively decreases blood pressure, but its influence on ...
Bertin, Nicole   +6 more
core   +3 more sources

Supplementary Table 2 from Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100

open access: gold, 2023
Juliet Richards   +12 more
openalex   +1 more source

Eplerenone as a novel treatment for persistent subretinal fluid following retinal detachment surgery

open access: yesAmerican Journal of Ophthalmology Case Reports, 2018
Purpose: To describe the clinical course of a patient with persistent subretinal fluid (SRF) after primary scleral buckle surgery for a rhegmatogenous retinal detachment (RRD) repair who was subsequently treated with oral eplerenone for resolution of SRF.
Arezu Haghighi, Jiun Do, Hossein Ameri
doaj   +1 more source

Cardiorenal syndrome [PDF]

open access: yes, 2015
published_or_final_versio
Pai, MCP
core   +1 more source

Home - About - Disclaimer - Privacy